Actively Recruiting

Age: 18Years - 80Years
All Genders
Healthy Volunteers
NCT06672250

The Correlation Between Circulatory Tumor Cells and Venous Thrombosis

Led by Chang Gung Memorial Hospital · Updated on 2025-09-24

120

Participants Needed

1

Research Sites

152 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Research indicates a strong correlation between cancer and thrombosis, with approximately 20% of blood clots in the U.S. being cancer-related, according to CDC data. Cancer patients face a 4-7 times higher risk of thrombosis compared to non-cancer individuals. Certain cancer treatments, such as chemotherapy and targeted therapy, elevate the likelihood of venous thromboembolism (VTE). Cancer patients with VTE exhibit a significantly higher hazard ratio (H.R.) of 3.4 compared to those without VTE. This study aims to explore three main topics: (1) Comparing the differences and similarities of leukocyte populations between cancer-associated thrombosis (CAT) and venous thromboembolism (VTE). (2) Characterizing the factors contributing to increased incidence of cancer-associated thrombosis (CAT), with the hypothesis that circulating tumor microemboli (CTM) may express more thrombosis-related proteins than CTCs. (3) Understanding the effects of aspirin or NOACs on cancer-associated thrombosis and CTM formation.

CONDITIONS

Official Title

The Correlation Between Circulatory Tumor Cells and Venous Thrombosis

Who Can Participate

Age: 18Years - 80Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Participants without cancer must have no history of cancer in the past five years
  • Participants with cancer must have pathology confirming a malignant tumor
  • Patients who have undergone catheter-based thrombectomy
  • Agree to undergo thrombectomy procedure
Not Eligible

You will not qualify if you...

  • Participants without cancer who are in shock
  • Participants without cancer who have severe sepsis
  • Participants with cancer who are in shock
  • Participants with cancer who have severe sepsis
  • Participants with cancer diagnosed within the past five years

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

New Taipei City TuCheng Hospital

New Taipei City, Taiwan

Actively Recruiting

Loading map...

Research Team

H

Hsin-Fu Lee, PhD

CONTACT

C

Chia-Hsun Hsieh, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here